D. Joshua

发表

Gallium scanning in the management of mediastinal Hodgkin's disease

B. Hutton, B. Hutton, H. Kronenberg, 1989, European journal of haematology.

The use of a commercially available immunoassay to determine the level of interleukin-6 in the serum of patients with myeloma.

D. Joshua, R. Brown, J. Gibson, 1991, Leukemia & lymphoma.

The oncoprotein phenotype of plasma cells from patients with multiple myeloma.

B. Pope, R. Brown, J. Gibson, 1994, Leukemia & lymphoma.

Single daily ceftriaxone and tobramycin in the empirical management of febrile neutropenic patients: a randomised trial.

H. Kronenberg, P. Vincent, P. Vincent, 1993, International journal of hematology.

Long-term survival in multiple myeloma is associated with a distinct immunological profile , which includes proliferative cytotoxic T-cell clones and a favourable Treg / Th 17 balance

N. Nassif, P. Fromm, D. Hart, 2013 .

Fulminant postsplenectomy sepsis

H. Kronenberg, J. Gibson, A. Perkins, 1988, The Medical journal of Australia.

Disease progression in patients with multiple myeloma is associated with a concurrent alteration in the expression of both oncogenes and tumour suppressor genes and can be monitored by the oncoprotein phenotype.

B. Pope, R. Brown, J. Gibson, 1997, Leukemia & lymphoma.

Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myeloma

R. Brown, J. Gibson, D. Joshua, 1992, British journal of haematology.

Aggressive natural killer cell leukemia/lymphoma

S. Dunkley, J. Gibson, D. Joshua, 1998, Pathology.

CD10-(CALLA)-Positive Lymphocytes in Myeloma: Evidence that they are a Malignant Precursor Population and are of Germinal Centre Origin.

R. Brown, J. Gibson, D. Joshua, 1989, Leukemia & lymphoma.

Low-grade lymphoma: the optimal timing.

J. Gibson, D. Joshua, P. Ho, 2004, Transplantation proceedings.

Long‐term follow up of sequential mobilisation and autologous transplantation with CD34‐selected cells in multiple myeloma: a multimodality approach

L. To, U. Hahn, R. Brown, 2004, Internal medicine journal.

Chronic myeloid leukaemia presenting as femoral head necrosis.

H. Kronenberg, D. Collis, J. Gibson, 2009, Scandinavian journal of haematology.

Cyclosporin A‐associated proteinuria

G. Duggin, H. Kronenberg, A. Bleasel, 1987, The Medical journal of Australia.

Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: evidence from the Ig heavy chain gene.

A. Morley, R. Brown, J. Gibson, 1993, Blood.

Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonal

B. Pope, R. Brown, J. Gibson, 1997, Bone Marrow Transplantation.

Aseptic meningitis associated with high dose intravenous immunoglobulin therapy.

H. Kronenberg, J. Gibson, D. Joshua, 1991, Journal of neurology, neurosurgery, and psychiatry.

Very high dose intravenous gammaglobulin in thrombocytopenia of pregnancy.

H. Kronenberg, J. Harris, P. Laird, 1989, Australian and New Zealand journal of medicine.

Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune-suppressed HLA-identical unrelated donor marrow transplant recipients. Australasian Bone Marrow Transplant Study Group.

K. Atkinson, C. Juttner, C. Arthur, 1995, Bone marrow transplantation.

Multiple myeloma: evidence that light chains play an immunoregulatory role in B-cell regulation.

H. Kronenberg, S. Francis, R. Brown, 1989, Hematologic pathology.

Leukaemias into the 21st century – part 2: the chronic leukaemias

Christina Brown, D. Joshua, H. Iland, 2013, Internal medicine journal.

CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilisation in multiple myeloma

R. Brown, J. Gibson, P. Dyson, 2000, Bone Marrow Transplantation.

Leukaemias into the 21st century: part 1: the acute leukaemias

D. Joshua, H. Iland, J. Gibson, 2012, Internal medicine journal.

Evolving transplant options for multiple myeloma: autologous and nonmyeloablative allogenic.

J. Gibson, D. Joshua, P. Ho, 2004, Transplantation proceedings.

Primary amyloidosis co-presenting with cervical and massive intra-abdominal lymphadenopathy.

H. Kronenberg, J. Gibson, D. Joshua, 1995, Leukemia & lymphoma.

Hemodialysis: an appropriate therapy in myeloma-induced renal failure.

D. Tiller, D. Joshua, L. Snowdon, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Collagenase digestion of trephine biopsies: rapid diagnosis of the dry tap with preservation of cytochemical reactivity.

H. Kronenberg, J. Gibson, D. Joshua, 1988, Pathology.

A randomised dosage study of ceftazidime with single daily tobramycin for the empirical management of febrile neutropenia in patients with hematological diseases.

H. Kronenberg, P. Vincent, H. Iland, 1994, International journal of hematology.

Acute promyelocytic leukaemia complicating multiple myeloma: evidence of different cell lineages.

S. Dunkley, H. Iland, J. Gibson, 1999, Leukemia & lymphoma.

Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS)

H. Iland, J. Gibson, D. Joshua, 2007, International journal of laboratory hematology.

Haemophilia and ITP

J. Gibson, D. Joshua, K. Rickard, 1984, The Medical journal of Australia.

Treatment of patients with Waldenström macroglobulinaemia: clinical practice update from the Myeloma Foundation of Australia Medical and Scientific Advisory Group

A. Zannettino, C. Tam, S. Harrison, 2022, Internal medicine journal.

Syngeneic stem cell transplantation for HIV‐related lymphoma

H. Iland, D. Joshua, J. Gibson, 1999, British journal of haematology.

C-reactive protein (CRP) levels do not reflect disease status in patients with multiple myeloma.

R. Brown, J. Gibson, D. Joshua, 1993, Leukemia & lymphoma.

The bone marrow plasma cell labeling index by flow cytometry.

B. Pope, R. Brown, J. Gibson, 1999, Cytometry.

Interleukin-6 receptor expression and saturation on the bone marrow cells of patients with multiple myeloma.

R. Brown, J. Gibson, D. Joshua, 1993, Leukemia.

Serum thymidine kinase as a prognostic indicator for patients with multiple myeloma: results from the MRC (UK) V Trial

I. Maclennan, J. Dunn, R. Brown, 1993, British journal of haematology.